1,384
Views
1
CrossRef citations to date
0
Altmetric
Coronaviruses

MERS-CoV seroconversion amongst Malaysian Hajj pilgrims returning from the Middle East, 2016–2018: results from the MERCURIAL multiyear prospective cohort study

, , , , , , , , , , , , , , , , & show all
Article: 2208678 | Received 07 Feb 2023, Accepted 25 Apr 2023, Published online: 23 May 2023

References

  • World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [Cited 2022 Oct 31]. Available from: https://covid19.who.int/.
  • Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324(15):1495–1496. doi:10.1001/jama.2020.19759.
  • Zhu Z, Lian X, Su X, et al. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020;21:224. doi:10.1186/s12931-020-01479-w.
  • European Centre for Disease Prevention and Control. Geographical distribution of confirmed MERS-COV cases by country of infection and year, from April 2012 - 3 October 2022. (2022, October 7). [Cited 2022 Oct 31]. Available from: https://www.ecdc.europa.eu/en/publications-data/geographical-distribution-confirmed-mers-cov-cases-country-infection-and-year-12.
  • World Health Organization. Prioritizing diseases for research and development in emergency contexts. [Cited 2022 Oct 31]. Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts.
  • Al-Tawfiq JA, Zumla A, Memish ZA. Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis. 2014 Oct;27(5):411–417. doi:10.1097/QCO.0000000000000089.
  • Kim KH, Tandi TE, Choi JW, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–213. doi:10.1016/j.jhin.2016.10.008.
  • Al-Tawfiq JA, El-Kafrawy SA, McCloskey B, et al. COVID-19 and other respiratory tract infections at mass gathering religious and sporting events. Curr Opin Pulm Med. 2022;28(3):192–198. doi:10.1097/MCP.0000000000000859.
  • Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. The Lancet 2006. 9515;367:1008–1015. doi:10.1016/s0140-6736(06)68429-8.
  • Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis. 2014;12(5):422–428. doi:10.1016/j.tmaid.2014.06.007.
  • Hoang VT, Gautret P, Memish ZA, et al. Hajj and Umrah mass gatherings and COVID-19 infection. Curr Trop Med Rep. 2020;7:133–140. doi:10.1007/s40475-020-00218-x.
  • Aberle JH, Popow-Kraupp T, Kreidl P, et al. Influenza A and B viruses but not MERS-CoV in Hajj pilgrims, Austria, 2014. Emerg Infect Dis. 2015;21:726–727. doi:10.3201/eid2104.141745.
  • Amin M, Bakhtiar A, Subarjo M, et al. Screening for Middle East respiratory syndrome coronavirus among febrile Indonesian Hajj pilgrims: a study on 28,197 returning pilgrims. J Infect Prev. 2018;19:236–239. doi:10.1177/1757177418765634.
  • Annan A, Owusu M, Marfo KS, et al. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health. 2015;20:807–812. doi:10.1111/tmi.12482.
  • Atabani SF, Wilson S, Overton-Lewis C, et al. Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015. Int J Infect Dis. 2016;47:10–14. doi:10.1016/j.ijid.2016.04.016.
  • Barasheed O, Rashid H, Alfelali M, et al. Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin. 2014;29:364–371. doi:10.1007/s12250-014-3507-x.
  • Benkouiten S, Charrel R, Belhouchat K, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20:1821–1827. doi:10.3201/eid2011.140600.
  • Gautret P, Charrel R, Belhouchat K, et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013;19:E315–E317. doi:10.1111/1469-0691.12174.
  • Gautret P, Charrel R, Benkouiten S, et al. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20:726–728. doi:10.3201/eid2004.131708.
  • Hashem AM, Al-Subhi TL, Badroon NA, et al. MERS-cov, influenza and other respiratory viruses among symptomatic pilgrims during 2014 Hajj season. J Med Virol. 2019;91:911–917. doi:10.1002/jmv.25424.
  • Koul PA, Mir H, Saha S, et al. Influenza not MERS CoV among returning Hajj and Umrah pilgrims with respiratory illness, kashmir, North India, 2014-15. Travel Med Infect Dis. 2017;15:45–47. doi:10.1016/j.tmaid.2016.12.002.
  • Ma X, Liu F, Liu L, et al. No MERS-CoV but positive influenza viruses in returning Hajj pilgrims, China, 2013-2015. BMC Infect Dis. 2017;17:715. doi:10.1186/s12879-017-2791-0.
  • Memish ZA, Almasri M, Turkestani A, et al. Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program. Int J Infect Dis. 2014;25:186–190. doi:10.1016/j.ijid.2014.06.003.
  • Refaey S, Amin MM, Roguski K, et al. Cross-sectional survey and surveillance for influenza viruses and MERS-CoV among Egyptian pilgrims returning from Hajj during 2012-2015. Influenza Other Respir Viruses. 2017;11:57–60. doi:10.1111/irv.12429.
  • Johari J, Hontz RD, Pike BL, et al. Multiyear prospective cohort study to evaluate the risk potential of MERS-COV infection among Malaysian Hajj pilgrims (mercurial): A study protocol. BMJ Open. 2021;11; doi:10.1136/bmjopen-2021-050901.
  • Ko JH, Müller MA, Seok H, et al. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests. Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2179–2186. doi:10.1007/s10096-017-3043-3. Epub 2017 Jul 11.
  • Müller MA, Meyer B, Corman VM, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015 May;15(5):559–564. doi:10.1016/S1473-3099(15)70090-3. Epub 2015 Apr 8. Erratum in: Lancet Infect Dis. 2015 Jun;15(6):629.
  • Alshukairi AN, Zheng J, Zhao J, et al. High prevalence of MERS-CoV infection in camel workers in Saudi arabia. mBio. 2018 Oct 30;9(5):e01985–18. doi:10.1128/mBio.01985-18.
  • Song YJ, Yang JS, Yoon HJ, et al. Asymptomatic Middle East respiratory syndrome coronavirus infection using a serologic survey in Korea. Epidemiol Health. 2018 Apr 15;40:e2018014), doi:10.4178/epih.e2018014.
  • Premila Devi J, Noraini W, Norhayati R, et al. Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro Surveill. 2014 May 8;19(18):20797), doi:10.2807/1560-7917.es2014.19.18.20797.
  • World Health Organization. Middle East respiratory syndrome coronavirus (MERS-COV) – Malaysia. [Cited 2022 Oct 31]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/08-january-2018-mers-cov-malaysia-en.
  • Ghapa N. Consumer protecton measures for Umrah package travellers in Malaysia. PalArch's Journal of Archaeology of Egypt / Egyptology. [Cited 2022 Oct 31]. Available from: https://archives.palarch.nl/index.php/jae/article/view/290.
  • Degnah AA, Al-amri SS, Hassan AM, et al. Seroprevalence of MERS-cov in healthy adults in western Saudi arabia, 2011–2016. J Infect Public Health. 2020;13:697–703. doi:10.1016/j.jiph.2020.01.001.
  • Liljander A, Meyer B, Jores J, et al. MERS-CoV Antibodies in humans, Africa, 2013–2014. Emerg Infect Dis. 2016;22(6):1086–1089. doi:10.3201/eid2206.160064.
  • Munyua P, Lattwein E, Corman VM, et al. No serologic evidence of Middle East respiratory syndrome coronavirus infection among camel farmers exposed to highly seropositive camel herds: A household linked study, Kenya, 2013. Am J Trop Med Hyg. 2017;96(6):1318–1324. doi:10.4269/ajtmh.16-0880.
  • Zohaib A, Saqib M, Athar MA, et al. Countrywide survey for MERS-coronavirus antibodies in dromedaries and humans in Pakistan. Virol Sin. 2018;33(5):410–417. doi:10.1007/s12250-018-0051-0.
  • Abbad A, Perera RA, Anga L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill. 2019 Nov;24(48):1900244. doi:10.2807/1560-7917.ES.2019.24.48.1900244.
  • Benkouiten S, Al-Tawfiq JA, Memish ZA, et al. Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review. Travel Med Infect Dis. 2019;28:15–26. doi:10.1016/j.tmaid.2018.12.002.
  • Benkouiten S, Charrel R, Belhouchat K, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20(11):1821–1827. doi:10.3201/eid2011.140600.
  • Al-Abdallat MM, Rha B, Alqasrawi S, et al. Acute respiratory infections among returning Hajj pilgrims—Jordan, 2014. J Clin Virol. 2017;89:34–37. doi:10.1016/j.jcv.2017.01.010.
  • Choe PG, Perera RAPM, Park WB, et al. MERS-CoV Antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017 Jul;23(7):1079–1084. doi:10.3201/eid2307.170310. Epub 2017 Jul 15.
  • Alshukairi AN, Khalid I, Ahmed WA, et al. Antibody response and disease severity in healthcare worker MERS survivors. Emerg Infect Dis. 2016;22(6). doi:10.3201/eid2206.160010.
  • Ko JH, Müller MA, Seok H, et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis. 2017 Oct;89(2):106–111. doi:10.1016/j.diagmicrobio.2017.07.006. Epub 2017 Jul 14.
  • Jeewandara C, Jayathilaka D, Gomes L, et al. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness. Sci Rep. 2021 Jan 21;11(1):2062), doi:10.1038/s41598-021-81629-2.
  • Marchi S, Viviani S, Remarque EJ, et al. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS One. 2021 Jul 2;16(7):e0253977), doi:10.1371/journal.pone.0253977.
  • Maciola AK, La Raja M, Pacenti M, et al. Neutralizing antibody responses to SARS-CoV-2 in recovered COVID-19 patients are variable and correlate with disease severity and receptor-binding domain recognition. Front Immunol. 2022 Jan 31;13:830710), doi:10.3389/fimmu.2022.830710.
  • Assiri A, McGeer A, Perl TM, et al. KSA MERS-CoV investigation team. hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013 Aug 1;369(5):407–416. doi:10.1056/NEJMoa1306742. Epub 2013 Jun 19. Erratum in: N Engl J Med. 2013 Aug 29;369(9):886.
  • Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Gerber SI; Jordan MERS-CoV investigation team. hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014 Nov 1;59(9):1225–1233. doi:10.1093/cid/ciu359. Epub 2014 May 14.
  • Park HY, Lee EJ, Ryu YW, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015 Jun 25;20(25):1–6. doi:10.2807/1560-7917.es2015.20.25.21169.
  • Hui DS, Azhar EI, Kim YJ, et al. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 Aug;18(8):e217–e227. doi:10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18.
  • Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017 Jul 14;17(1):498), doi:10.1186/s12879-017-2576-5.
  • Majumder MS, Brownstein JS, Finkelstein SN, et al. Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg. 2017 Jun 1;111(6):261–269. doi:10.1093/trstmh/trx046.
  • Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect. 2015 Aug;6(4):269–278. doi: 10.1016/j.phrp.2015.08.006. Epub 2015 Sep 5. Erratum in: Osong Public Health Res Perspect. 2016 Apr;7(2):138.
  • Hemida MG, Perera RA, Al Jassim RA, et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19; doi:10.2807/1560-7917.es2014.19.23.20828.
  • Okba NMA, Raj VS, Widjaja I, et al. Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections. Emerg Infect Dis. 2019;25:1868–1877. doi:10.3201/eid2510.190051.
  • Alhabbab RY, Algaissi A, Mahmoud AB, et al. MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals. Clin Infect Dis. 2022 Jun 8: ciac456. doi:10.1093/cid/ciac456. Epub ahead of print.
  • Zhao J, Alshukairi AN, Baharoon SA, et al. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol. 2017 Aug 4;2(14):eaan5393. doi:10.1126/sciimmunol.aan5393. Epub 2017 Aug 4.
  • Mok CK, Zhu A, Zhao J, et al. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: An observational cohort study. Lancet Infect Dis. 2021;21(3):385–395. doi:10.1016/s1473-3099(20)30599-5.